Stocklytics Platform
Asset logo for symbol NVCR
Novocure Ltd
NVCR56
$26.33arrow_drop_down2.51%-$0.67
Asset logo for symbol NVCR
NVCR56

$26.33

arrow_drop_down2.51%
Key Stats
Open$26.90
Prev. Close$27.02
EPS-1.39
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range25.87
27.03
52 Week Range10.87
34.06
Ratios
EPS-1.39
Fundamentals
Payout Ratio-
Industry average yield2.90%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

NVCR-
US Healthcare Sector-
US Market-
warning

NVCR / Market

NVCR lose to the US Market which returned 0.66% over the last twenty four hours.
warning

NVCR / Healthcare Sector

NVCR lose to the US Healthcare sector which returned 2.53% over the last twenty four hours.

Novocure Ltd (NVCR) Statistics

Novocure Ltd (NVCR) is a leading global oncology company that develops and commercializes innovative tumor treatment solutions. The company is committed to changing the way cancer is treated by utilizing its proprietary technology called Tumor Treating Fields (TTFields). Novocure's TTFields therapy has been proven to slow or stop the growth of solid tumors and has shown significant improvement in survival rates for patients with certain types of cancer. This groundbreaking therapy is delivered through a portable, non-invasive device that can be used at home or in a clinical setting. Novocure's mission is to extend survival and improve quality of life for cancer patients worldwide.
When it comes to valuation metrics, Novocure Ltd (NVCR) has a price-to-earnings (P/E) ratio of 78.23 and a price-to-sales (P/S) ratio of 16.54. These metrics indicate that the company's stock may be trading at a premium compared to its earnings and sales. However, it is important to note that valuation metrics should not be considered in isolation and should be analyzed in conjunction with other factors to make informed investment decisions.
add Novocure Ltd to watchlist

Keep an eye on Novocure Ltd

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Novocure Ltd (NVCR) stock's performance compared to its sector and the market over the past year?

Over the past year, Novocure Ltd (NVCR) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 22.58%, Novocure Ltd has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 50.22%, it has fallen short of the market average. This comparison highlights Novocure Ltd's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Novocure Ltd (NVCR) stock?

The PE ratio for Novocure Ltd (NVCR) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Novocure Ltd (NVCR) stock?

The Earnings Per Share (EPS) for Novocure Ltd (NVCR), calculated on a diluted basis, is -$1.39. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Novocure Ltd (NVCR) stock?

The operating margin for Novocure Ltd (NVCR) is -20.69%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Novocure Ltd (NVCR) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Novocure Ltd (NVCR) is -$140.61M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Novocure Ltd (NVCR) have?

Novocure Ltd (NVCR) has a total debt of $675.63M. The net debt, which accounts for cash and cash equivalents against the total debt, is $490.2M.

Take Your Investments to a Whole New Level